Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein

Hybridoma

Volumn 25, Issue 5, 2006, Pages 271-277

  Choi, Jin Kyu ^a   Park, Seok Ju ^a   Jun, Yong Chul ^a   Oh, Jae Min ^a   Jeong, Byung Hoon ^a   Lee, Hyun Pil ^a   Park, Sue Nie ^b   Carp, Richard I ^c   Kim, Yong Sun ^a  

^a Hallym University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; GLYCINE ZIPPER PROTEIN; HYBRID PROTEIN; PRION PROTEIN; PRION PROTEIN ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; EXTRACELLULAR MATRIX; FEMALE; HAMSTER; HYBRIDOMA; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; SCRAPIE; STRUCTURE ACTIVITY RELATION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PRION; WESTERN BLOTTING;

CRICETINAE; MAMMALIA; MUS;

AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CRICETINAE; EPITOPE MAPPING; FEMALE; HYBRIDOMAS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; PRIONS; PRPC PROTEINS;

EID: 33947231205     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2006.25.271     Document Type: Article

References (24)

1. Prusiner SB: The prion diseases. Brain Pathol 1998;8:499-513.
2. DeArmond SJ, and Prusiner SB: Etiology and pathogenesis of prion diseases. Am J Pathol 1995;146:785-811.
3. Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-144.
4. Prusiner SB: Prions. Proc Natl Acad Sci USA 1998;95:13363-13383.
5. Barry RA and Prusiner SB: Monoclonal antibodies to the cellular and scrapie prion proteins. J Infect Dis 1986;154:518-521.
6. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, and Diringer H: Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987;61:3688-3693.
7. Sc)-specific epitope defined by a monoclonal antibody. Nature 1997;390:74-77.
8. Yokoyama T, Kimura KM, Ushiki Y, Yamada S, Morooka A, Nakashiba T, Sassa T, and Itohara S: In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J Biol Chem 2001;276:11265-11271.
9. C degradation. J Neurochem 2004;89:454-463.
10. Sc replication in infected cells. J Biochem 2005;280:11247-11258.
11. James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, and Cohen FE: Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci USA 1997;94:10086-10091.
12. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, and Wuthrich K: NMR structure of the mouse prion protein domain PrP(121-231). Nature 1996;382:180-182.
13. Horiuchi M, Baron GS, Xiong L, and Caughey B: Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J Biol Chem 2001;276:15489-15497.
14. Choi YG, Kim JI, Jeon YC, Park SJ, Choi EK, Rubenstein R, Kascsak RJ, Carp RI, and Kim YS: Nonenzymatic glycation at the N-terminus of pathogenic prion protein in transmissible spongiform encephalopathies. J Biol Chem 2004;279:30402-30409.
15. Enari M, Flechsig E, and Weissmann C: Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci USA 2001;98:9295-9299.
16. Heppner FL, Musahl C, Arrighi I, Klein MA, Rulicke T, Oesch B, Zinkernagel RM, Kalinke U, and Aguzzi A: Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 2001;294:178-182.
17. Wopfner F, Weidenhofer G, Schneider R, von Brunn A, Gilch S, Schwarz TF, Werner T, and Schatzl HM: Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 1999;289:1163-1178.
18. Yost CS, Lopez CD, Prusiner SB, Myers RM, and Lingappa VR: Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 1990;343:669-672.
19. Pillot T, Drouet B, Pincon-Raymond M. Vandekerckhove J, Tosseneu M, and Cambaz J: A non-fibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons. J Neurochem 2000;75:2298-2308.
20. Come JH, Fraser PE, and Lansbury PT: A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc Natl Acad Sci USA 1993;90:5959-5963.
21. Kim S, Jeon TJ, Oberai A, Yang D, Schmidt JJ, and Bowie JU: Transmembrane glycine zippers: Physiological and pathological roles in membrane proteins. Proc Natl Acad Sci USA 2005;102: 14278-14283.
22. Sc aggregates. J Virol 2005;79:12355-12364.
23. Sc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem 2004;279:39671-39676.
24. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, and Hawke S: Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003;422:80-83.